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Efficacy of stent-supported subintimal angioplasty
in the treatment of long iliac artery occlusions
Young-Guk Ko, MD, Sanghoon Shin, MD, Kwang Joon Kim, MD, Jung-Sun Kim, MD, PhD,
Myeong-Ki Hong, MD, PhD, Yangsoo Jang, MD, PhD, Won-Heum Shim, MD, PhD, and
Donghoon Choi, MD, PhD, Seoul, Korea
Background: Subintimal angioplasty (SA) is becoming increasingly accepted as a revascularization technique for chronic
arterial occlusive disease. However, its efficacy in iliac artery occlusions has not been established. Therefore, we
investigated the procedural and clinical outcomes of subintimal angioplasty in long iliac artery occlusions and compared
them with those of intraluminal angioplasty (IA) in nonocclusive stenotic iliac artery lesions.
Methods:Weretrospectively analyzed data from151 consecutive patientswith long (>5 cm) iliac artery lesions (204 limbs)who
underwent angioplasty with primary stent implantation fromOctober 2004 through July 2008. Among them, 100 lesions in
100 patients were treated with intentional SA, and 104 lesions in 82 patients were treated with IA. We compared the baseline
characteristics and immediate and long-term outcomes of iliac artery lesions treated with SA versus IA.
Results: Baseline characteristics showed that longer lesions and critical limb ischemia were found more frequently in the
SA group, whereas diabetes and combined femoropopliteal lesions were present more often in the IA group. The technical
success rate of SA was lower than that of IA (93.0% vs 99.0%; P  .048). However, there was no significant difference in
the procedure-related complications between the SA and IA groups (4.0% vs 4.8%; P  .779). Primary patency rates for
SA and IA were 96.8% and 98.0% at 1 year, and 93.9% and 90.6% at 2 years, respectively (log rank P  .656).
Conclusion: Stent-supported SA in occlusive iliac lesions was safe and showed a high long-term patency rate comparable
to that of IA performed in nonocclusive iliac lesions despite longer lesion length. Thus, SA with implantation of stents is
an effective technique for the treatment of chronic long iliac artery occlusion. (J Vasc Surg 2011;54:116-22.)
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0For complex, multifocal, or long stenotic or occlusive
lesions of iliac arteries, surgery has been the standard treat-
ment.1,2 However, endovascular therapy is a less invasive
procedure that has shown improved clinical outcomes in
iliac lesions due to recent advances in devices and skills.2,3
Recent studies using stents in iliac arteries reported high
technical success, good mid- and long-term patency, and
low procedural morbidity and mortality.4-7 This led to the
removal of the length restriction on common iliac artery
stenoses and the inclusion of more complex iliac artery
lesions in the definitions of type A and B lesions in the
updated TransAtlantic Inter-Societal Consensus (TASC) II
guidelines, for which endovascular therapy is more prefer-
entially recommended.2,3 However, extensive iliac occlu-
sions involving external iliac arteries still belong to type C
and D lesions, for which surgical treatment is considered
the primary therapy.
From theDivision of Cardiology, Severance CardiovascularHospital, Yonsei
University Health System.
Supported by the Healthcare Technology R&D Project, Ministry for
Health, Welfare, and Family Affairs, Republic of Korea (No. A085012
and A000385); a grant from the Korea Health 21 R&D Project, Ministry
of Health and Welfare, Republic of Korea (No. A085136); and the
Cardiovascular Research Center, Seoul, Korea.
Competition of interest: none.
Reprint requests: Donghoon Choi, MD, PhD, Division of Cardiology,
Severance Cardiovascular Hospital, Yonsei University Health System, 250
Seongsanno, Seodaemun-gu, Seoul, Korea (e-mail: cdhlyj@yuhs.ac).
The editors and reviewers of this article have no relevant financial relationships
to disclose per the JVS policy that requires reviewers to decline review of any
manuscript for which they may have a competition of interest.
0741-5214/$36.00t
Copyright © 2011 by the Society for Vascular Surgery.
doi:10.1016/j.jvs.2010.11.127
116In the treatment of occlusive lesions with endovascular
herapy, there are two technical methods to cross the
cclusion with a wire, either by an intraluminal or subinti-
al approach. Intentional subintimal angioplasty (SA),
hich was first described by Bolia et al8 in 1989, offers
ome theoretic advantages over conventional angioplasty.
his technique is based on the intentional creation of an
xtraluminal channel between the intimal and medial layers
r within the medial layer of the arterial wall, displacing the
rue lumen filled with atherothrombotic materials to one
ide of the vessel wall. SA has been primarily used for
ecanalizing long femoropopliteal or tibial occlusions with
elatively high technical success rates; however, only a few
tudies have described the outcomes of SA in iliac le-
ions.9-12 Thus, the aim of this study was to investigate the
rocedural and clinical outcomes of SA in long occlusive
esions of iliac arteries and compare them with those of
ntraluminal angioplasty (IA) in nonocclusive long lesions
f iliac arteries.
ATERIALS AND METHODS
Patient population. Between January 2004 and De-
ember 2008, stent-supported endovascular treatment was
erformed in 344 iliac arteries of 266 consecutive patients
228 men; mean age, 65.1  9.2 years). Among them, we
dentified 151 patients (204 limbs) with long (5 cm) iliac
rtery stenotic or occlusive lesions who were treated with
ercutaneous angioplasty (percutaneous transluminal angio-
lasty [PTA]) and primary stenting. Sixty-nine patients (100
imbs) with iliac artery occlusions (diameter stenosis 100 
%, lesion length 97  35.9 mm) were treated with inten-
ional SA.Conventional IAwas performed in 82 patients (104
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Volume 54, Number 1 Ko et al 117limbs) with nonocclusive, stenotic iliac artery lesions (diame-
ter stenosis 80.3 10.2%, lesion length 62.0 24.2mm). All
patients had symptomatic de novo chronic iliac artery disease.
Patients with restenotic lesions, emboli, acute thrombi, or
dissections were excluded. Patients who were previously
treated with stent grafts were also excluded. Before undergo-
ing therapeutic angiography, all patients underwent physical
evaluation; noninvasive hemodynamic evaluation, including
ankle-brachial index (ABI), thigh-brachial index (TBI), seg-
mental pressures, and pulse volume recordings; and at least
one imaging study, including color duplex ultrasound, com-
puted tomography (CT), or magnetic resonance angiogra-
phy. We investigated baseline data and immediate and long-
term outcomes in the limbs with long stenotic or occlusive
iliac artery lesions and compared them between patients who
underwent SA versus IA.
The institutional review board at Severance Hospital,
Yonsei University Health System, approved this study and
waived requirements for informed consent for this retro-
spective analysis.
Angioplasty procedure. All procedures were per-
Fig 1. A representative case of subintimal angioplasty
A, Computed tomography (CT) angiography showing
B, Subintimal angioplasty in a contralateral femoral app
loop form. C, Angiography after successful wire passa
recanalized common and external iliac arteries with m
implantation of a proximal balloon-expandable stent andformed under local anesthesia, supplemented with intrave- pous sedation and analgesia when required. Systemic hep-
rin of 5000 IU was administered to achieve an activated
lotting time200 seconds. For the treatment of occlusive
liac artery lesions, intentional SA with primary stenting was
erformed. The first attempt of recanalization was generally
ade with an antegrade approach either from the brachial
rtery using a 7F Shuttle sheath (Cook, Bloomington, Ind)
r from the contralateral femoral artery using a 7F con-
ralateral Balkin sheath (Cook). If an antegrade approach
ailed to cross the lesions, a retrograde approach from the
psilateral femoral artery was carried out. If both attempts
ailed, a combined antegrade and retrograde approach with
alloon dilation of subintimal space was performed. The
ntentional creation of a subintimal channel at the stump of
he occlusion was carried out using a straight 0.035-inch
ydrophilic guidewire (Terumo, Tokyo, Japan), which was
urther advanced to form a loop at the tip of the guidewire
Fig 1). The loop of wire was supported by a 5F Multipur-
ose catheter (Torkon NB; Cook) and advanced through
he subintimal plane until the occlusion was passed and the
ire re-entered the true lumen. All SA procedures were
e occlusion of left common and external iliac arteries.
l occlusion of left common and external iliac arteries.
by advancing a 0.035-inch hydrophilic guidewire in a
to distal true lumen and balloon predilation showing
le dissection intimal flaps. D, Final angiography after
tal self-expandable stent.at th
tota
roach
ge in
ultiperformed without use of re-entry devices.
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July 2011118 Ko et alFor the treatment of nonocclusive stenotic iliac artery
lesions, either an ipsilateral retrograde approach with a 7F
introducer sheath (Terumo) or contralateral antegrade ap-
proach with a 7F contralateral Balkin (Cook) was used. After
the intraluminal or subintimal passage of a 0.035-inch guide-
wire through the iliac artery lesions, the target limb artery was
dilated with a 6- to 8-mm peripheral balloon catheter. Self-
expandable nitinol stents (Smart; Cordis, Miami Lakes, Fla;
Zilver, Cook; Heracules, S and G Biotech, Seongnam,
Gyeonggi-do,Korea)were usually preferred for long-segment
lesions and balloon-expandable stents (Palmaz Genesis, Cor-
dis; Express, Boston Scientific, Natick, Mass) for short-
segment lesions or common iliac ostial lesions. Stent
diameters ranged from 7 to 10 mm. Poststent dilation
was performed if there was residual stenosis 30%. Imme-
diately after PTA, the pressure gradient over the treated
lesion was measured by simultaneous recording of the
mean systolic pressures at the proximal and distal sides of
the treated lesion. If there was a significant residual stenosis
(30%), flow-limiting dissection, or a pressure gradient
20 mm Hg, additional stents were implanted. In the pres-
ence of significant infrainguinal lesions, combined PTA was
performed. Angioplasty in tibial arteries was carried out only
when patients had clinical signs of critical limb ischemia and
less than one patent distal run-off vessel. After successful
recanalization, all patients received the combination of aspirin
100 mg/day and either clopidogrel 75 mg/day or cilostazol
200mg/day for at least 1 year. In cases with large thrombotic
burden or poor distal run-off, warfarin was added to the
antiplatelet agents at the operator’s discretion.
Follow-up. All patients who underwent technically suc-
cessful procedures were clinically followed at 1 month and
every 3 months thereafter. Noninvasive hemodynamic evalu-
ations, including ABI, segmental pressures, and pulse volume
recordings were performed before discharge from the hospital
and thereafter regularly every 6months or in cases of symptom
deterioration. Follow-up CT angiography or ultrasound eval-
uation with color duplex ultrasound was performed within 1
month after the procedure and thereafter regularly every year
or in cases of symptom deterioration. Follow-up angiography
was performed if any symptoms worsened by one clinical
category, the TBI or ABI decreased by 0.15 on pulse vol-
ume recording, or restenosis of50% was seen on a noninva-
sive imaging study.
Definitions and statistical analysis. Technical angio-
graphic success was defined as recanalization with ante-
grade flow and 30% residual stenosis on postprocedural
angiography. A major complication was defined as any
event, regardless of severity, that required treatment with a
therapeutic intervention or rehospitalization within 30 days
of the procedure. Run-off at the tibial level was determined
by the number of patent vessels present with a maximum of
3 (scored as 0, 1, 2, or 3). Primary endpoint was a cumu-
lative survival free of reintervention, above-ankle amputa-
tion of the index limb, or restenosis50% (RAS). Second-
ary endpoints include major adverse cardiovascular event
(MACE), major adverse limb event (MALE), and primary
patency. MACE was defined as a composite of myocardial cnfarction, stroke, or death. MALE was defined as a com-
osite of above-ankle amputation of the index limb or
eintervention. Primary patency after the index procedure
as defined as patent limb segments without recurrent
tenosis or the need for further intervention. The treated
imb segments were considered patent during follow-up
ccording to hemodynamic criteria (TBImaintained within
.15 of the postprocedure maximum) and imaging criteria
no evidence of restenosis exceeding 50% at the site of
TA). A peak velocity 300 cm/s or a lesion velocity to
djacent segment velocity ratio3.5 by duplex was consid-
red a significant (50%) restenosis.
To compare the efficacy of SA with that of IA, per-limb
nalysis was performed. Continuous variables are reported
s mean  standard deviation, and categorical variables as
requencies and percentages. 2 tests and unpaired Stu-
ent’s t tests were used for comparison between the SA and
A groups. The cumulativeMALE free survival and primary
atency rate and limb salvage rate were estimated using
aplan-Meier methods with the log-rank test. Determi-
ants of restenosis were evaluated by univariate analysis
sing Cox proportional hazards regression. Findings were
onsidered significant if the resulting P value was less than
.05. All statistical tests were performed with SPSS 18.0
SPSS Inc, Chicago, Ill).
ESULTS
Baseline characteristics. Patient demographics, clini-
able I. Baseline characteristics of the lesions treated
ith intraluminal versus subintimal angioplasty
ariable
Intraluminal
angioplasty
Subintimal
angioplasty
P
value
imbs (n) 104 100
ale (n [%]) 93 (89.4%) 87 (87.9%) .729
ge (years) 65.4  10.1 64.2  11.5 .413
iabetes mellitus (n [%]) 55 (52.9%) 36 (36.0%) .015
ypertension (n [%]) 61 (58.7%) 57 (57.0%) .811
urrent smoker (n [%]) 64 (61.5%) 66 (66.0%) .508
ypercholesterolemia (n [%]) 58 (63.0%) 63 (67.7%) .502
oronary artery disease (n [%]) 66 (63.5%) 63 (63.0%) .946
revious stroke (n [%]) 14 (13.5%) 8 (8.0%) .209
hronic renal failure (n [%]) 13 (12.5%) 13 (13.0%) .915
eart failure (ejection fraction
 45%; n [%]) 11 (10.6%) 12 (12.0%) .748
ritical limb ischemia (n [%]) 12 (11.5%) 36 (36.0%).001
emoropopliteal disease
(n [%]) 56 (53.8%) 40 (40.0%) .048
atent tibial arteries (n [%]) .252
0 or 1 21 (20.2%) 27 (27.0%)
2 or 3 83 (79.8%) 73 (73.0%)
ischarge medication (n [%])
Aspirin 99 (95.2%) 95 (95%) .949
Clopidogrel 85 (81.7%) 74 (74.0%) .183
Cilostazol 38 (36.5%) 38 (38.0%) .829
Statin 82 (78.8%) 76 (76.0%) .627
Angiotension-converting
enzyme inhibitor/
angiotensin receptor
blocker 60 (57.7%) 54 (54.0%) .595al characteristics, and risk factors are presented in Table I.
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Volume 54, Number 1 Ko et al 119Baseline clinical characteristics did not differ significantly
between the SA and IA groups, with the following excep-
tions: diabetes and combined femoropopliteal lesions were
more common in the IA group, whereas critical limb isch-
emia was more common in the SA group. The iliac lesions
treated with SA were longer and required more and longer
stents. Initial ABI and TBI in the SA group were signifi-
cantly lower than those of the IA group (ABI: 0.41 0.23
vs 0.55 0.23, respectively; P .001; TBI: 0.48 0.21 vs
0.66  0.25, respectively; P  .001).
Immediate outcomes. Procedural data are shown in
Table II. The technical success rates of both angioplasty
methods were high, but higher for IA than SA (99.0% vs
93.0%; P  .048). After successful procedures, ABI and
TBI were similar between the two groups (ABI: 0.86 
0.25 vs 0.88  0.23, P  .611, TBI: 0.98  0.19 vs
0.96 0.20, P .595, for SA and IA, respectively). In the
IA group, recanalization was attempted with the contralat-
eral antegrade approach in 54 (51.9%) lesions, with the
ipsilateral retrograde approach in 46 (44.2%) lesions, and
with the brachial approach in four (3.8%) lesions. In the SA
Table II. Procedural data: intraluminal versus subintimal
Variable
Intralumin
(n 
Lesion type (TASC II) (n [%])
Type B 34 (
Type C 53 (
Type D 17 (
Location of the lesion (n [%])
CIA only 34 (
EIA only 37 (
CIA and EIA 33 (
Diameter stenosis (%) 80.3
Lesion length (mm) 62.0
Technical success (n [%]) 103 (
Number of used stents 1.2
Balloon-expandable stents 0.3
Self-expandable stents 1.0
Stent diameter (mm), (ranges, mm) 8.5  1.
Stent length (mm), (ranges, mm) 77.5  30
Combined treatment (n [%])
Common femoral artery lesions (n [%]) 14 (
Femoropopliteal lesions (n [%]) 33 (
Infrapopliteal lesions (n [%]) 4 (
Contralateral iliac lesions (n [%]) 63 (
By intraluminal angioplasty (n [%]) 50 (
By subintimal angioplasty (n [%]) 13 (
Procedure-related complications (n [%]) 5 (
Major complications (n [%]) 2 (
Rupture (n [%]) 1 (
Distal embolization (n [%]) 4 (
Death (n [%]) 0 (
Ankle-brachial index
Pre 0.55
Post 0.88
Thigh-brachial index
Pre 0.66
Post 0.96
CFA, Common femoral artery; CIA, common iliac artery; EIA, external iliagroup, recanalization was attempted with the contralateral flntegrade method in 45 (45.0%) lesions and with the
psilateral retrograde approach in 10 (10.0%) lesions. Of
he remaining 45 lesions in the SA group, 29 (29.0%) were
pproached with a combined brachial antegrade and ipsi-
ateral retrograde method and 16 (16.0%) with a combined
ontralateral antegrade and ipsilateral retrograde method.
oncomitant treatment of distal lesions, such as femoro-
opliteal artery or tibial artery stenoses, was performed at
imilar frequencies in the two groups. However, there was
trend toward more frequent combined treatment of com-
on femoral artery lesions in the SA group (24.0% vs
3.5%; P  .053).
The cause of technical failure in all six lesions with failed
A was inability to re-enter the true lumen after initial entry
nto subintimal channel despite a combined antegrade and
etrograde approach. All lesions with failed SA showed
eavy calcification of occluded iliac arteries. However, the
ncidence of procedure-related complications did not differ
ignificantly between the SA and IA groups. One case of
liac artery rupture occurred in the IA group, which was
reated with implantation of a covered stent. Frequency of
plasty
gioplasty
)
Subintimal angioplasty
(n  100) P value
.001
%) 0 (0.0%)
%) 15 (15.0%)
%) 85 (85.0%)
.006
%) 29 (29.0%)
%) 19 (19.0%)
%) 52 (52.0%)
.2 100  0 .001
.2 97  35.9 .001
%) 94 (94.0%) .048
1.6  0.6 .001
0.4  0.5 .038
1.1  0.8 .089
14) 8.6  1.3 (7-14) .441
9-180) 94.6  33.1 (37-160) .001
%) 24 (24.0%) .053
%) 28 (28.0%) .561
) 2 (2.0%) .443
%) 53 (53.0%) .275
%) 14 (14.0%)
%) 39 (39.0%)
) 4 (4.0%) .779
) 1 (1%) .999
) 0 (0.0%) .326
) 4 (4.0%) .955
) 0 (0.0%) .999
3 0.41  0.23 .001
3 0.86  0.25 .611
5 0.48  0.21 .001
0 0.98  0.19 .595
ry; TASC, TransAtlantic Inter-Societal Consensus.angio
al an
104
32.7
51.0
16.3
32.7
35.6
33.0
 10
 24
99.0
 0.4
 0.5
 0.5
2 (6-
.5 (3
13.5
31.7
3.8%
60.6
48.1
12.5
4.8%
1.9%
1.0%
3.8%
0.0%
 0.2
 0.2
 0.2
 0.2ow-limiting distal embolization was similar between the
d
d
s
i
s
9
r
9
d
w
w
c
i
d
a
s
D
c
i
w
o
s
H
l
s
p
t
l
v
o
a
t
o
c
c
T
C
S
C
H
D
L
D
R
W
L
JOURNAL OF VASCULAR SURGERY
July 2011120 Ko et alIA and the SA groups (n  5 [3.8%] vs n  4 [4.0%],
respectively; P .955). One limb of each group was treated
with embolectomy using a Forgathy catheter. The other
limbs were treated with aspiration and catheter-based ad-
ministration of thrombolytics. No mortality was associated
with the procedures in either group. In addition, the
groups did not differ significantly in the use of aspirin,
clopidogrel, cilostazol, statins, and angiotensin-converting
enzyme inhibitors or angiotensin receptor blockers as post-
procedural medications.
Midterm outcomes. Among the patients whose pro-
cedures were technically successful, 78 (103 limbs) in the
IA group and 77 (94 limbs) in the SA group were followed
for a median period of 30.1 months (interquartile range,
19.1-42.5 months). The cumulative RAS-free survival rates
did not differ significantly between the IA and the SA
group; these were, respectively, 98.0% (95% confidence
interval [CI], 100.8%-95.2%) and 96.8% (95% CI, 99.4%-
93.2%) at 1 year, and 90.6% (95% CI, 97.4%-83.8%) and
93.9% (95% CI, 99.3%-88.5%) at 2 years (log rank P 
.656; Fig 2). The primary patency rates were identical with
the cumulative RAS-free survival rates at each time point for
both groups. During the follow-up period, in the IA group,
one limb required a transmetatarsal and another a below-
the-knee amputation; in the SA group, one limb required a
toe amputation. Significant restenosis or reocclusion was
found in seven iliac lesions of the IA group and five iliac
lesions of the SA group. Two of the reoccluded lesions from
each group were treated successfully with repeat angio-
plasty. All the other lesions were treated medically because
of patients’ refusal or poor medical conditions. The 2-year
MALE-free survival rates did not differ between the IA and
the SA group (98.0% [95% CI, 100.8%-95.2%] vs 95.2%
[95% CI, 100.0%-90.4%], log rank P  .552).
During the follow-up period, 17 patients with 24
treated limbs (10 limbs in the IA group and 14 limbs in the
Fig 2. Primary patency of iliac artery lesions after intraluminal
versus subintimal angioplasty.SA group) died. The cause of death was ischemic heart misease in seven patients, malignancy in four, infectious
isease (pneumonia, urinary tract infection) in five, and
troke in two. None of the deaths was directly related to
schemia of treated limbs. The 2-year overall mortality free
urvival (91.0% [95% CI, 97.2%-84.8%] vs 89.4% [95% CI,
6.2%-82.6%], log rank P .243) andMACE-free survival
ates (91.0% [95% CI, 97.2%-84.8%] vs 88.3% [95% CI,
5.3%-81.3%], log rank P  .210) were not significantly
ifferent between the IA and the SA groups.
Univariate Cox proportional hazard regression analysis
as performed to investigate risk factors of restenosis in the
hole study population (Table III). The analysis included
linical and procedural factors such as SA, critical limb
schemia, heart failure, diabetes, renal failure, presence of
istal lesions requiring PTA, female gender, lesion length,
nd lesion location. However, none of the factors was
ignificantly associated with increased risk of restenosis.
ISCUSSION
The present study demonstrates that intentional SA
ombined with primary stent implantation for revascular-
zation of occlusive iliac lesions can be performed safely
ith a high technical success rate despite an extensive
cclusion length. The technical success rate of SA was
lightly lower than that of IA for nonocclusive lesions.
owever, procedure-related complication rates were simi-
ar in both groups and relatively low (4%). In addition, SA
upported with primary stenting achieved a high primary
atency rate (93.9%) at 2 years, which was comparable with
hat of IA (90.6%).
PTA was initially recommended for treatment of focal
esions.1,2 However, recent clinical studies with new endo-
ascular devices and stents have demonstrated improved
utcomes of endovascular treatment in more extensive
ortoiliac occlusive disease.4,13,14 Several studies reported
he efficacy of IA with stent implantation for the treatment
f chronic total occlusion of iliac arteries.15-19 The techni-
al success rate ranged from 92% to 99%, and the major
omplication rate varied between 7% and 19%. Frequent
able III. Predictive risk factors of restenosis: Univariate
ox proportional hazard regression analysis
Hazard
ratio
95% confidence
interval P
ubintimal angioplasty 1.640 0.274-9.818 .588
ritical limb ischemia 2.403 0.401-14.393 .228
eart failure 1.894 0.212-16.957 .568
istal limb lesions requiring
percutaneous transluminal
angioplasty 1.623 0.271-9.725 .596
esion length 0.996 0.971-1.023 .790
iabetes 1.675 0.280-10.026 .572
enal failure 1.601 0.179-14.326 .674
omen 1.698 0.189-15.229 .636
esion location in external
iliac artery 2.131 0.237-19.151 .499ajor complications were artery rupture, distal emboliza-
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Volume 54, Number 1 Ko et al 121tion, stent thrombosis, and access site hematoma or infec-
tions. Primary patency ranged from 75% to 95% at 1 year
and from 63% to 90% at 3 to 5 years. Gandini et al17
performed primary stenting in 138 patients with iliac artery
occlusion and reported a technical success rate of 99% and
a primary patency rate of 90% at 3 years. This patency rate is
comparable with the results of IA or SA with stenting in our
study. However, Ozkan et al18 reported relatively unfavor-
able outcomes of angioplasty in iliac occlusions. They used
a “wire-loop technique” in 127 iliac artery occlusions and
experienced a major complication rate of 22%. The primary
patency rate was about 75% at 2 years and 63% at 5 years. It
was not clear from their report whether they performed
intentional SA or how frequently they implanted stents. To
date, only a few studies have described the outcomes of SA
in iliac lesions.9-12 A recent study by Chen et al12 reported
favorable outcomes of SA in chronic iliac artery occlusions.
The technical success rate was 84% and the major compli-
cation rate 3.0%, which were comparable with those of the
present study. The primary patency rates at 1 and 2 years
were 86% and 76%, respectively, slightly lower than in our
study. This may be explained by inclusion of more patients
with end-stage renal failure and previous bypass surgery
compared with our study.
The technical success rate of SA in femoropopliteal
occlusions varies between 80% and 90%, and the 1-year
patency rate ranges between 50% and 70%.9,20 The effect of
stenting on the outcomes of SA is not known. We previ-
ously reported on improved technical success and midterm
patency with stent-supported SA in femoropopliteal occlu-
sions.21 However, there has been no randomized trial
comparing SA methods with versus without stenting. In
the present study, technical failure of SA was associated
with presence of heavily calcified lesions, which hinder the
passage of the wire back into true lumen. This problemmay
be overcome by using newly developed true lumen re-entry
devices. Jacobs et al10 reported that chronic iliac artery
occlusions in 20 patients, which could not be crossed using
standard catheter and wire techniques, were successfully
treated using the re-entry devices. In the present study, SA
failure did not result in major adverse clinical events or
complications requiring intervention. The frequency of
distal embolization-limiting distal blood flow during the
procedure was relatively low in both the SA and IA groups,
and most cases were managed successfully with additional
minor procedures. Thus, SA in iliac artery occlusions seems
to be a safe procedure.
Previous studies identified diabetes, critical limb isch-
emia, poor distal runoff, renal insufficiency, and female
gender22,23 as factors associated with restenosis or reocclu-
sion after IA of iliac lesions. However, none of these factors
was significantly associated with increased risk of restenosis
in our study. Similarly, Chen et al12 also could not find any
independent risk factor for reocclusion in their study. Once
a total occlusion of iliac arteries is successfully recanalized
by stent-supported angioplasty, few factors seem to have an
influence on the patency.There have been no randomized controlled studies
omparing efficacies of surgical treatment and PTA in
ortoiliac occlusive disease. However, several recent regis-
ry data showed that PTA could achieve comparable out-
omes as bypass surgery in the treatment of aortoiliac
isease.24 Kashyap et al24 reported that secondary patency
ates (97% vs 95%) were similar between aortobifemoral
ypass grafting and angioplasty with or without stenting in
atients with TASC II C or D disease, although the primary
atency at 3 years was significantly higher for bypass surgery
han for angioplasty (93% vs 74%; P  .002). Burke et al25
ound no significant difference between aortofemoral by-
ass surgery and stenting in the long-term freedom from
mputation or revision procedures. However, bypass sur-
ery was associated with more frequent complications.
fficacy of new devices for crossing total occlusions or
therectomy in iliac arteries is still not defined. A small
tudy with 43 patients demonstrated feasibility of laser
ngioplasty in chronic iliac occlusions with a technical
uccess rate of 95.3%.26 However, the efficacy of laser-
ssisted recanalization in iliac occlusions needs to be vali-
ated in larger studies.
Our data demonstrated that recanalization of iliac ar-
ery occlusion can be accomplished by SA with little mor-
idity and with a high primary patency rate despite long
esion length. Therefore, except for cases of heavily calcified
esions, stent-supported SA might be considered a first-line
herapy for chronic aortoiliac occlusions.
Our study has several limitations. This study was a
etrospective analysis of single-center registry data with a
imited number of study subjects. In the present study, we
erformed a per-limb analysis of patients that had more
han one limb treated. Therefore, interdependence of bi-
ateral diseases at the patient level could not be ruled out. In
ddition, our intention was not to perform a precise head-
o-head comparison of the two angioplasty techniques, SA
nd IA, but to roughly estimate the outcomes of SA relative
o those of similarly severe lesion types treated with IA. We
id not perform routine intravascular ultrasound imaging
o prove that a new channel was subintimal or not. How-
ver, in all patients, we could confirm dissection flap at the
roximal stump of the occlusion after intentional wire
avigation into the subintimal channel. Furthermore, the
oop of wire with a supporting catheter could be advanced
istally without hard resistance in most cases, which would
ot have been possible if the wire were moved within the
eavily atherosclerotic true lumen. As Lipsitz et al27
ointed out, the shaping of the wire into a wide loop larger
han the diameter of true lumen is an indication that the
ire is located in the subintimal plane.
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